LONG-TERM USE OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Retina
; 44(2): 222-229, 2024 Feb 01.
Article
in En
| MEDLINE
| ID: mdl-37903288
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Endophthalmitis
/
Wet Macular Degeneration
/
Macular Degeneration
Limits:
Aged80
/
Child
/
Child, preschool
/
Humans
Language:
En
Journal:
Retina
Year:
2024
Document type:
Article